<?xml version="1.0" encoding="UTF-8"?>
<p>The earliest eligible study identified was carried out in 1968 [
 <xref rid="pntd.0006627.ref036" ref-type="bibr">36</xref>]. Since then RVFV seroprevalence has been reported in 31 African countries (
 <xref ref-type="fig" rid="pntd.0006627.g002">Fig 2</xref>). The focus of the majority of studies has been in eastern Africa with 48/174 (27.6%) seroprevalence studies being in Kenya alone (
 <xref ref-type="fig" rid="pntd.0006627.g002">Fig 2</xref>).
</p>
